HealthDay - SATURDAY, Jan. 28 (HealthDay News) -- For some people a change in
the seasons can trigger a loss of energy or even clinical depression,
according to an expert who describes how to cope with seasonal affective
disorder.
Health
Test Might Predict Risk of Lung Cancer's Return (HealthDay)
HealthDay - THURSDAY, Jan. 26 (HealthDay News) -- A new industry-funded study
suggests that a molecular test can provide insight into whether patients
are at high risk of a relapse after surgical treatment for a form of lung
cancer.
Statins May Stave Off Liver Cancer in People With Hepatitis B (HealthDay)
HealthDay - THURSDAY, Jan. 26 (HealthDay News) -- Popular
cholesterol-lowering statins may also lower risk for liver cancer among
people with hepatitis B, a new study shows. Hepatitis B, an inflammation
of the liver due to the hepatitis B virus, is one of the main causes of
liver cancer.
Health Tip: Manage Pain During Childbirth (HealthDay)
HealthDay - (HealthDay News) -- Pain is a virtual certainty during
childbirth, but there are ways to ease the discomfort without
medication.
Acupuncture May Boost Pregnancy Success Rates (HealthDay)
HealthDay - FRIDAY, Jan. 27 (HealthDay News) -- When a couple is trying to
have a baby and can't, it can be emotionally and financially draining. But
help may be available in an unexpected form: acupuncture.
Positive Reinforcement May Help Patients Take Their Meds (HealthDay)
HealthDay - FRIDAY, Jan. 27 (HealthDay News) -- Positive reinforcement, such as
receiving small, unexpected gifts and introducing upbeat thoughts into
daily routines, seems to help patients with high blood pressure take their
medication as directed, according to a new study of black Americans.
IV Acetaminophen Linked to More Child Overdoses (HealthDay)
HealthDay - FRIDAY, Jan. 27 (HealthDay News) -- Following the U.S. Food Drug
Administration's approval last year of an intravenous formulation of
acetaminophen for fever and pain in a hospital setting, researchers warn
that use of the preparation could lead to serious overdoses, particularly
among the youngest patients.
Drug Approved for Advanced Kidney Cancer (HealthDay)
HealthDay - FRIDAY, Jan. 27 (HealthDay News) -- Inlyta (axitinib) has been
approved by the U.S. Food and Drug Administration to treat advanced renal
cell carcinoma in people who haven't responded to another drug.
Bydureon Approved for Type 2 Diabetes (HealthDay)
HealthDay - FRIDAY, Jan. 27 (HealthDay News) -- Bydureon (exenatide extended
release), Amylin Pharmaceuticals' long-acting version of the diabetes drug
Byetta, has been approved by the U.S. Food and Drug Administration.
Page 1 of 219


